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Caine. E. D. (1980) N . Engl. J. Med. 303, [585] [586] 13. Wettstein, A. ( 1983) Schweiz. Arch. Neurol. Nerrrochirug. 14. Christie, J. E., Shering, A,, Ferguson 27. Mitchelson, F. (1988) I'heirmcicol. Ther. 37,357-423 28. Anwar-UI, S., Gilani Although the cholinergic dysfunction in Alzheimer's disease has been extensively investigated, it is now also well established that there is a deficiency in f0rebra.h 5-hydroxytryptamine (5-HT; serotonin) systems. Concentrations of 5HT and its metabolite, 5-hydroxyindole acetic acid, are reduced and 5HT,-and SHTp-eceptor density decreased, the most pronounced changes being observed in the hippocampus and frontal and temporal cortices (Bowen el al., 1983; Cross el ul., 1984; Palmer et al., 1987) . Despite these decreases in serotonergic markers in patients with Alzheimer's disease, serotonergic therapies have received little attention. However, there is now a wealth of evidence from preclinical studies that 5HT can modulate learning and memory processes either directly or via interactions with other neurotransmitters.
Early pharmacological studies focused on avoidance tasks and suggested that 5HT inhibited learning. The 5HT synthesis inhibitor, p-chlorophenylalanine (PCPA), at doses which produce a 80-90% depletion of brain 5HT, increased passive avoidance performance when administered immediately before training (Brody, 1970; Rake, 1973) . However, a number of authors failed to find any effect of PCPA on passive avoidance, one-way active avoidance or a water-motivated escape task (Essman, 1970; Fibiger et al., 1978; Bam- Abbreviations used: 5HT. 5-hydroxytryptamine (serotonin); PCPA. p-chlorophenylalanine; SHTP, 5-hydroxytryptophan; PCA. p-chloroamphetamine; 8-OH-DPAT, K-hydroxy-2-(di-n-propylamino)tetralin. mer, 1982; Vanderwolf, 1987) . Administration of the precursor, 5-hydroxytryptophan (SHTP), immediately before training produced an impairment of passive avoidance although again some studies found no effect (Garzon el al., 198 1 ; Bammer, 1982) . Similarly, the 5HT-releasing compound, p-chloroamphetamine (PCA), impaired both active and passive avoidance when administered immediately before training, but not when administered after training, and this deficit appeared to be due to the enhanccd release of 5HT (Ogren, 1982 (Ogren, , 1986 . These results indicated that increased 5HT function might interfere with association processes which are active during acquisition, but did not disrupt consolidation of the learned information into long-term memory. On the other hand, PCA has been shown to facilitate the performance of young and aged rats on an appetitive task, the Stone maze (Altman, 1985; Normile & Altman, 1986) . Interestingly, the avoidance deficit induced by PCA was blocked by pretreatment with the uptake inhibitors, fluoxetine and zimeldine, which block the ability of PCA to release 5HT. Zimeldine and another uptake inhibitor, alaproclate, when administered alone enhanced avoidance learning in mice, but this effect was not blocked by the 5HT antagonist, cyproheptadine (Altman et al., 1984) .
Antagonist studies have also produced contradictory results. Methysergide, mianserin, ketanserin and pirenperone have been reported to facilitate, impair or have no effect on avoidance tasks (Altnian & Normile, 1986; Bammer, 1982; Wetzel et al., 1980) . The direction of effect appears to be determined in part by the time of administration of the drug and the degree of training of the animals. Altman & Normile (1986 , 1987 found that these antagonists all improved retention of a lick-suppression avoidance task when they were administered after training or before the retention trial, VOl. 17 BIOCHEMICAL SOCIETY TRANSACTIONS but impaired learning when administered shortly before training. Methysergide did not impair performance of an appetite-motivated task, the radial arm maze (Bcatty & Rush, 1983) , and it may be that 5HT has different effects on positively reinforced tasks from those on negatively reinforced avoidance tasks. This hypothesis is strengthened by studies on the 5HT 1,-selective agonist, 8-hydroxy-2-(di-n-propylamino)tetralin (8-OI-I-DPAT), on two types of task with a spatial component, the water maze and a delayed non-match to sample task.
The water maze is an aversively motivated task, where the rat learns over several trials to locate a hidden platform, or 'island', in an opaque tank of water (Morris, 1981) . Untreated rats were trained on this task to find the island in one position and then their performance was measured under drug when given a new island position to learn. The four possible island positions are shown in Fig. 1 . Using this paradigm, anticholinergic drugs such as scopolamine have been shown to produce an impairment as shown by an increase in the time taken to find the island on successive trials and a decrease in the amount of time they spcnd in thc vicinity of the island compared with controls (Hunter et al., 1986; Hunter & Roberts, 1988) .
Male Lister Hooded rats which had been previously trained to one island position were treated with either saline or 8-OH-DPAT (60, 100 or 200 pg/kg). They were then given six trials to a new island position followed by a seventh trial where the island was removed completely from the pool. 8-OH-DPAT produced a dose-dependent increase in swimming speed and there were no significant differences between the treated groups and controls over the six trials with regard to latency and path length taken to find the 
8-OH-DPAT
island, although the groups given the two higher doscs of 8-OH-DPAT had longer latencies on the final three trials. On the seventh 'no-island' trial, rats which have learnt the correct position of the island spend significantly more time where the island used to be compared with the other possible locations of the island. This is shown as an increase in the time spent in the island quadrant and an increase the number of times the rats crossed over the actual point whcrc the island had been located ('annulus crossings'). Rats which remember the task and know the four possible island locations but which have not learnt which is the correct position in this particular experiment will visit each of thc four possible locations with equal frequency. Table 1 shows that 8-OH-DPAT decreased the percentage time in the island quadrant and the number of times the rat crossed the actual island position in a dose-dependent fashion, indicating an impairment of performance. Higher doses of 8-OH-DPAT could not be used as they caused a pronounced 5HT behavioural syndrome. The 5HT2 antagonist, ketanserin, had no effect on this task. The delayed non-match-to sample task is a rewarded task which is also impaired by anticholinergic drugs (Dunnett, 1985) . The rat is presented with a stimulus and then, after a variable delay, given a choice between the first stimulus and a second stimulus. In the non-matching task the rat has to choose the stimulus that was not presented previously. 8-OH-DPAT did not cause an impairment cf this task at doses which impair performance on the water maze (Table 2) .
Therefore it seems that pre-test administration of 8-OH-DPAT can have different effects depending on the nature of the task. This interpretation is supported by the fact that it has been reported to impair passive avoidance learning (Ogren, 1985) . However, Winter & Peti (1987) did find that 8-OH-DPAT produced an impairment in radial arm maze performance, but this was only observed at high doses. Certainly, SHT,.-receptors appear to be involved in mediating serotonergic effects on learning. This is perhaps not surprising as 5HT,, binding is especially high in the hippocampus (Middlemiss el al., 1986) , an area known to be involvcd in memory (Olton & Samuelson, 1978) .
Another way in which 5HT might modulate learning and memory is via effects on acetylcholinc. The 5HT uptake inhibitor, alaproclate, potentiates the actions of muscarinic agonists such as oxotremorine (Ogren el al., 1985) . Our own studies indicated that this is due to a prolongation of the agonist effects as well as an increase in the actual magnitude of the response. In addition, several studies have indicated that cholinergic-serotonergic interactions may be important in learning. Swonger & Rech (1972) found that 5HTP was capable of reversing scopolamine-induced deficits in passive avoidance and spontancous alternation and combined administration of oxotremorine and alaproclate facilitated the performance of mice in a passive avoidance task at doses that were ineffective when administered separately (Altman et al., 1987) . Finally, the impairment produced by scopolamine on acquisition and retention of an active avoidance task was increased by a dose of PCPA that produccd no effects on these parameters when administered alone (Vanderwolf, 1987) .
The limited clinical studies that have been undertaken suggest that while serotonergic antagonists can sometimes impair memory, this may correlate with their sedative effects (Curran et al., 1986) . Treatment with uptake inhibitors has generally produced no effect, although one study reported that zimeldine reversed ethanol-induced deficits in free recall of a word list (Weingartner et al., 1983) . More studies with selective agonists and antagonists on a wider variety of tasks may clarify further the role of 5HT in memory and learning. Interactions between serotonergic and cholinergic systems T h e original idea suggesting that antagonists or inverse agonists at the benzodiazepine receptor may exert promnestic or nootropic properties, was based on a simple analogy: as benzodiazepine rcccptor agonists induce anterograde amnesia, antagonists or, at least, inverse agonists at the benzodiazepine receptor should produce effects opposite to those of agonists, even at the level of information processing.
T h e basis of both amnestic and promnestic properties of agonists and antagonists/inverse agonists, respectively, has been assumed to be essentially similar. Thus, the amnestic properties of agonists seem to be primarily the result of an impairment of stimulus filtering (Cole, 1986; Clark et al., Abbreviations used: GABA, y-aminobutyric acid; TBPS, t-butylhicyclophosphorothionate; DMCM, methyl 6,7-dimethoxy-4-ethyIcarboline-3-carboxy late.
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1983; Roehrs er al., 1983) which could be measured best in signal-detection tasks. Accordingly, the beneficial effects of inverse agonists in cognitive tasks have been assumed to depend primarily on improved learning in contrast to effects on retrieval of information. Subsequently, in dealing with the pharmacological profile of the P-carbolinc ZK 9 3 426, an antagonist at the benzodiazepine receptor, the hypothesis that such compounds produce promnestic effects on the basis of a disinhibitory mechanism at cortical cholinergic afferent neurons has been developed (Sarter et a/., 1988) .
T h e substantia innominata seems likely to represent one major anatomical locus of such a GABAergic-cholinergic interaction. 
